Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Flyvbjerg

Showing results (231-240 of 271) with videos related to

Pageof 28
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 30, 2010
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetesNilani Jeyaratnaganthan, Kurt Højlund, Jens Peter Kroustrup, et al.
The American Journal of Cardiology|September 13, 2015
Interplay Between Adiponectin and Pro-Atrial Natriuretic Peptide and Prognosis in Patients With ST-Segment Elevation Myocardial InfarctionSøren Lindberg, Jan S Jensen, Søren Hoffmann, et al.
AIDS (London, England)|July 24, 2009
Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled studyBirgitte R Hansen, Lilian Kolte, Steen B Haugaard, et al.
American Heart Journal|August 10, 2010
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trialRagnhild Røysland, Serge Masson, Torbjørn Omland, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetesRoni Nielsen, Anders Jorsal, Rasmus S Tougaard, et al.
Ugeskrift for Laeger|May 19, 2016
[Sleep impairment is a threat to good health]Alice Jessie Clark, Thea Suldrup Jørgensen, Jens Bonke, et al.
Physiological Reports|August 15, 2015
Investigation of metabolic changes in STZ-induced diabetic rats with hyperpolarized [1-13C]acetateUlrich Koellisch, Christoffer Laustsen, Thomas S Nørlinger, et al.
Scientific Reports|April 27, 2021
The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetesJakob Appel Østergaard, Fanny Jansson Sigfrids, Carol Forsblom, et al.
The Journal of Invasive Cardiology|January 8, 2009
Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary interventionSune Haahr-Pedersen, Mette Bjerre, Allan Flyvbjerg, et al.
Diabetes Care|June 28, 2014
Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetesDaniel Gordin, Carol Forsblom, Nicolae M Panduru, et al.
Pageof 28

Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 30, 2010
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetesNilani Jeyaratnaganthan, Kurt Højlund, Jens Peter Kroustrup, et al.
The American Journal of Cardiology|September 13, 2015
Interplay Between Adiponectin and Pro-Atrial Natriuretic Peptide and Prognosis in Patients With ST-Segment Elevation Myocardial InfarctionSøren Lindberg, Jan S Jensen, Søren Hoffmann, et al.
AIDS (London, England)|July 24, 2009
Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled studyBirgitte R Hansen, Lilian Kolte, Steen B Haugaard, et al.
American Heart Journal|August 10, 2010
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trialRagnhild Røysland, Serge Masson, Torbjørn Omland, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetesRoni Nielsen, Anders Jorsal, Rasmus S Tougaard, et al.
Ugeskrift for Laeger|May 19, 2016
[Sleep impairment is a threat to good health]Alice Jessie Clark, Thea Suldrup Jørgensen, Jens Bonke, et al.
Physiological Reports|August 15, 2015
Investigation of metabolic changes in STZ-induced diabetic rats with hyperpolarized [1-13C]acetateUlrich Koellisch, Christoffer Laustsen, Thomas S Nørlinger, et al.
Scientific Reports|April 27, 2021
The pattern-recognition molecule H-ficolin in relation to diabetic kidney disease, mortality, and cardiovascular events in type 1 diabetesJakob Appel Østergaard, Fanny Jansson Sigfrids, Carol Forsblom, et al.
The Journal of Invasive Cardiology|January 8, 2009
Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary interventionSune Haahr-Pedersen, Mette Bjerre, Allan Flyvbjerg, et al.
Diabetes Care|June 28, 2014
Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetesDaniel Gordin, Carol Forsblom, Nicolae M Panduru, et al.
Pageof 28